PETHEMA-BLIN-01/PET069014 (BLIN-01)

NCT03523429 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Low rate of recruitment

Conditions

Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL

Interventions

DRUG: blinatumomab

Sponsor

PETHEMA Foundation